Vertex Pharmaceuticals Incorpor

Historical 13F Holders

Symbol
VRTX
CUSIP
92532F100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92532F100 since 12/18/2024, largest first.

Filer % of Class Filed
Capital World Investors 13G/A 10.1% 5/14/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 7.5% 4/30/2026
Event 3/31/2026
Capital Research Global Investors 13G/A 7.0% 11/13/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
FMR LLC 13G/A
3.6% 2/12/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1,808 239 M $125B
2026 Q2 1,781 242 M $120B
2026 Q1 1,716 238 M $106B
2025 Q4 1,691 242 M $110B
2025 Q3 1,539 236 M $92.2B
2025 Q2 1,583 241 M $107B
2025 Q1 1,630 240 M $117B
2024 Q4 1,579 237 M $95.3B
2024 Q3 1,564 235 M $109B
2024 Q2 1,564 236 M $110B
2024 Q1 1,504 236 M $98.1B
2023 Q4 1,452 236 M $95.8B
2023 Q3 1,293 236 M $82.2B
2023 Q2 1,292 238 M $83.4B
2023 Q1 1,218 240 M $75.1B
2022 Q4 1,229 237 M $68.4B
2022 Q3 1,138 237 M $68.6B
2022 Q2 1,119 236 M $66.1B
2022 Q1 1,083 235 M $60.9B
2021 Q4 1,044 230 M $50.4B
2021 Q3 942 232 M $41.9B
2021 Q2 987 233 M $46.8B
2021 Q1 1,006 236 M $50.7B
2020 Q4 976 239 M $57.0B
2020 Q3 957 243 M $66.0B
2020 Q2 971 243 M $70.6B
2020 Q1 866 245 M $58.3B
2019 Q4 816 244 M $53.4B
2019 Q3 712 247 M $41.8B
2019 Q2 721 246 M $45.2B
2019 Q1 745 246 M $45.2B
2018 Q4 712 244 M $40.4B
2018 Q3 702 243 M $46.8B
2018 Q2 694 242 M $41.2B
2018 Q1 690 241 M $39.2B
2017 Q4 650 240 M $35.9B
2017 Q3 615 238 M $36.1B
2017 Q2 584 236 M $30.4B
2017 Q1 527 236 M $25.8B
2016 Q4 492 236 M $17.4B
2016 Q3 494 241 M $21.0B
2016 Q2 489 240 M $20.7B
2016 Q1 503 242 M $18.8B
2015 Q4 522 236 M $29.6B
2015 Q3 497 235 M $24.5B
2015 Q2 503 230 M $28.4B
2015 Q1 483 234 M $27.6B
2014 Q4 478 230 M $27.4B
2014 Q3 438 234 M $26.2B
2014 Q2 418 227 M $21.5B
2014 Q1 397 224 M $15.8B